Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00212550 · ClinicalTrials.gov registry record

Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb

A clinical trial, sponsored by NYU Langone Health.

Completed
Registry status
10
Enrollment target

NCT00212550 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00212550 has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
10 participants
Enrollment target

Study Summary

Obtain sputum smears within one day to rule out TB

Interventions

  • PROCEDURE Obtain standard three daily sputum samples vs. three samples on the first day for the diagnosis of pulmonary TB.

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2006-01
Est. Completion 2012-01

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT00212550

The ClinicalTrials.gov registry entry for NCT00212550 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Obtain standard three daily sputum samples vs. three samples on the first day for the diagnosis of pulmonary TB. is the first listed.

NCT00212550 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00212550 about?

NCT00212550 is a clinical study titled "Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb". Obtain sputum smears within one day to rule out TB

What is the current status of trial NCT00212550?

This trial is currently completed. The enrollment target is 10 participants. The study started on 2006-01. Estimated completion is 2012-01.

What interventions are being tested in trial NCT00212550?

The interventions under investigation include: Obtain standard three daily sputum samples vs. three samples on the first day for the diagnosis of pulmonary TB. (PROCEDURE).

Who is sponsoring clinical trial NCT00212550?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.